NCT04779983View on ClinicalTrials.gov

IL-6 as a Biomarker for Personalized Treatment of PR

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

July 30, 2021

Study Completion Date

August 1, 2021

Conditions

Rheumatoid Arthritis

Trial Locations (1)

34295

UH Montpellier, Montpellier

All Listed Sponsors

lead

University Hospital, Montpellier

OTHER

NCT04779983 - IL-6 as a Biomarker for Personalized Treatment of PR | Biotech Hunter | Biotech Hunter